Human adenovirus Ad36 and its E4orf1 gene enhance cellular glucose uptake even in the presence of inflammatory cytokines

Biochimie

Volumn 124, Issue , 2016, Pages 3-10

  Na, Ha Na ^a   Dubuisson, Olga ^a   Hegde, Vijay ^a   Nam, Jae Hwan ^b   Dhurandhar, Nikhil V ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b The Catholic University of Korea   (South Korea)

Author keywords

3T3 L1; Adipocytes; Glycemic control; MCP1; Preadipocytes; TNF

Indexed keywords

CYTOKINE; DOXYCYCLINE; E4ORF1 PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 4; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN; CCL2 PROTEIN, MOUSE; ONCOPROTEIN; TUMOR NECROSIS FACTOR;

3T3 CELL LINE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE VECTOR; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HUMAN ADENOVIRUS 36; HUMAN ADENOVIRUS C; HUMAN ADENOVIRUS INFECTION; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; NULL CELL; OPEN READING FRAME; PLAQUE FORMING CELL; PROADIPOCYTE; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RECEPTOR UPREGULATION; VIRUS STRAIN; ADENOVIRIDAE; ADENOVIRUS INFECTION; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; VIROLOGY;

3T3-L1 CELLS; ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADIPOSE TISSUE; ANIMALS; CHEMOKINE CCL2; GLUCOSE; HUMANS; MICE; ONCOGENE PROTEINS, VIRAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84962360238     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.11.005     Document Type: Article

References (52)

1. E. Fabbrini, F. Magkos, B.S. Mohammed, T. Pietka, N.A. Abumrad, B.W. Patterson, A. Okunade, and S. Klein Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity Proc. Natl. Acad. Sci. U. S. A. 106 2009 15430 15435
2. H. Liang, P. Tantiwong, A. Sriwijitkamol, K. Shanmugasundaram, S. Mohan, S. Espinoza, R.A. Defronzo, J.J. Dube, and N. Musi Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects J. Physiol. 591 2013 2897 2909
3. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J. Clin. Invest. 117 2007 175 184
4. M.F. Gregor, and G.S. Hotamisligil Inflammatory mechanisms in obesity Annu. Rev. Immunol. 29 2011 415 445
5. H. Kanda, S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, and M. Kasuga MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity J. Clin. Invest. 116 2006 1494 1505
6. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91
7. H. Bruunsgaard Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations Eur. Cytokine Netw. 13 2002 389 391
8. Z. Gao, D. Hwang, F. Bataille, M. Lefevre, D. York, M.J. Quon, and J. Ye Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex J. Biol. Chem. 277 2002 48115 48121
9. N. Kamei, K. Tobe, R. Suzuki, M. Ohsugi, T. Watanabe, N. Kubota, N. Ohtsuka-Kowatari, K. Kumagai, K. Sakamoto, M. Kobayashi, T. Yamauchi, K. Ueki, Y. Oishi, S. Nishimura, I. Manabe, H. Hashimoto, Y. Ohnishi, H. Ogata, K. Tokuyama, M. Tsunoda, T. Ide, K. Murakami, R. Nagai, and T. Kadowaki Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance J. Biol. Chem. 281 2006 26602 26614
10. S.E. Shoelson, J. Lee, and A.B. Goldfine Inflammation and insulin resistance J. Clin. Invest. 116 2006 1793 1801
11. J.K. Kim, Y.J. Kim, J.J. Fillmore, Y. Chen, I. Moore, J. Lee, M. Yuan, Z.W. Li, M. Karin, P. Perret, S.E. Shoelson, and G.I. Shulman Prevention of fat-induced insulin resistance by salicylate J. Clin. Invest. 108 2001 437 446
12. M. Nixon, D.J. Wake, D.E. Livingstone, R.H. Stimson, C.L. Esteves, J.R. Seckl, K.E. Chapman, R. Andrew, and B.R. Walker Salicylate downregulates 11beta-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization Diabetes 61 2012 790 796
13. M. Membrez, F. Blancher, M. Jaquet, R. Bibiloni, P.D. Cani, R.G. Burcelin, I. Corthesy, K. Mace, and C.J. Chou Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice FASEB J.:Official Publ. Fed. Am. Soc. Exp. Biol. 22 2008 2416 2426
14. Y. Cao, D.C. Dubois, H. Sun, R.R. Almon, and W.J. Jusko Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats J. Pharmacol. Exp. Ther. 339 2011 896 904
15. M. Yuan, N. Konstantopoulos, J. Lee, L. Hansen, Z.W. Li, M. Karin, and S.E. Shoelson Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 293 2001 1673 1677
16. B.E. Vitola, S. Deivanayagam, R.I. Stein, B.S. Mohammed, F. Magkos, E.P. Kirk, and S. Klein Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents Obes. (Silver Spring) 17 2009 1744 1748
17. K.F. Petersen, S. Dufour, D.B. Savage, S. Bilz, G. Solomon, S. Yonemitsu, G.W. Cline, D. Befroy, L. Zemany, B.B. Kahn, X. Papademetris, D.L. Rothman, and G.I. Shulman The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome Proc. Natl. Acad. Sci. U. S. A. 104 2007 12587 12594
18. S. Klein, B. Mittendorfer, J.C. Eagon, B. Patterson, L. Grant, N. Feirt, E. Seki, D. Brenner, K. Korenblat, and J. McCrea Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease Gastroenterology 130 2006 1564 1572
19. M. Bougoulia, A. Triantos, and G. Koliakos Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women Horm. (Athens) 5 2006 259 269
20. R. Cancello, and K. Clement Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue BJOG 113 2006 1141 1147
21. K. Clement, N. Viguerie, C. Poitou, C. Carette, V. Pelloux, C.A. Curat, A. Sicard, S. Rome, A. Benis, J.D. Zucker, H. Vidal, M. Laville, G.S. Barsh, A. Basdevant, V. Stich, R. Cancello, and D. Langin Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects FASEB J. 18 2004 1657 1669
22. R.E. Gray, C.J. Tanner, W.J. Pories, K.G. MacDonald, and J.A. Houmard Effect of weight loss on muscle lipid content in morbidly obese subjects Am. J. Physiol. Endocrinol. Metab. 284 2003 E726 E732
23. N.V. Dhurandhar When commonsense does not make sense Int. J. Obes. 36 2012 1332 1333
24. A.B. Goldfine, V. Fonseca, K.A. Jablonski, Y.D. Chen, L. Tipton, M.A. Staten, and S.E. Shoelson Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial Ann. Intern. Med. 159 2013 1 12
25. A.B. Goldfine, P.R. Conlin, F. Halperin, J. Koska, P. Permana, D. Schwenke, S.E. Shoelson, and P.D. Reaven A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance Diabetologia 56 2013 714 723
26. J. Ye, and O.P. McGuinness Inflammation during obesity is not all bad: evidence from animal and human studies, American journal of physiology Endocrinol. Metab. 304 2013 E466 E477
27. E. Faghihimani, A. Aminorroaya, H. Rezvanian, P. Adibi, F. Ismail-Beigi, and M. Amini Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes Endocr. Pract.:Official J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol. 18 2012 826 833
28. J. Koska, E. Ortega, J.C. Bunt, A. Gasser, J. Impson, R.L. Hanson, J. Forbes, B. de Courten, and J. Krakoff The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study Diabetologia 52 2009 385 393
29. N.V. Dhurandhar A framework for identification of infections that contribute to human obesity Lancet Infect. Dis. 11 2011 963 969
30. I. Aldhoon-Hainerova, H. Zamrazilova, R.L. Atkinson, L. Dusatkova, B. Sedlackova, P. Hlavaty, Z.P. Lee, M. Kunesova, and V. Hainer Clinical and laboratory characteristics of 1179 Czech adolescents evaluated for antibodies to human adenovirus 36 Int. J. Obes. 2013
31. W. Lin, O. Dubuisson, R. Rubicz, N. Liu, D.B. Allison, J.E. Curran, A.G. Comuzzie, J. Blangero, C.T. Leach, H. Goring, and N.V. Dhurandhar Long term changes in adiposity and glycemic control are associated with past adenovirus infection Diabetes Care 36 2013 701 707
32. R. Krishnapuram, E.J. Dhurandhar, O. Dubuisson, H. Kirk-Ballard, S. Bajpeyi, N. Butte, M.S. Sothern, E. Larsen-Meyer, S. Chalew, B. Bennett, A.K. Gupta, F.L. Greenway, W. Johnson, M. Brashear, G. Reinhart, T. Rankinen, C. Bouchard, W.T. Cefalu, J. Ye, R. Javier, A. Zuberi, and N.V. Dhurandhar Template to improve glycemic control without reducing adiposity or dietary fat Am. J. Physiol. Endocrinol. Metab. 300 2011 E779 E789
33. N.V. Dhurandhar Is obesity caused by an adenovirus? Expert Rev. Anti Infect. Ther. 10 2012 521 524
34. H.N. Na, and J.H. Nam Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation J. Infect. Dis. 205 2012 914 922
35. M. Pasarica, A.C. Shin, M. Yu, H.M. Ou Yang, M. Rathod, K.L. Jen, S. MohanKumar, P.S. MohanKumar, N. Markward, and N.V. Dhurandhar Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats Obes. (Silver Spring) 14 2006 1905 1913
36. P.M. Rogers, N. Mashtalir, M.A. Rathod, O. Dubuisson, Z. Wang, K. Dasuri, S. Babin, A. Gupta, N. Markward, W.T. Cefalu, and N.V. Dhurandhar Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36 Diabetes 57 2008 2321 2331
37. Z.Q. Wang, W.T. Cefalu, X.H. Zhang, Y. Yu, J. Qin, L. Son, P.M. Rogers, N. Mashtalir, J.R. Bordelon, J. Ye, and N.V. Dhurandhar Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling Diabetes 57 2008 1805 1813
38. O. Dubuisson, E.J. Dhurandhar, R. Krishnapuram, H. Kirk-Ballard, A.K. Gupta, V. Hegde, E. Floyd, J.M. Gimble, and N.V. Dhurandhar PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells Endocrinology 152 2011 3648 3660
39. N.V. Dhurandhar Insulin sparing action of adenovirus 36 and its E4orf1 protein J. Diabetes Its Complicat. 27 2013 191 199
40. E.J. Dhurandhar, O. Dubuisson, N. Mashtalir, R. Krishnapuram, V. Hegde, and N.V. Dhurandhar E4orf1: a novel Ligand that improves glucose disposal in cell Culture PLoS One 6 8 2011 e23394
41. N.V. Dhurandhar, L. Geurts, R.L. Atkinson, L. Casteilla, K. Clement, P. Gerard, M. Vijay-Kumar, J.H. Nam, M. Nieuwdorp, G. Trovato, T.I. Sorensen, A. Vidal-Puig, and P.D. Cani Harnessing the beneficial properties of adipogenic microbes for improving human health Obes. Rev.:Official J. Int. Assoc. Study Obes. 2013
42. R. Krishnapuram, E.J. Dhurandhar, O. Dubuisson, V. Hegde, and N.V. Dhurandhar Doxycycline-regulated 3T3-L1 preadipocyte cell line with inducible, stable expression of adenoviral E4orf1 gene: a cell model to study insulin-independent glucose disposal PloS One 8 2013 e60651
43. S. Chirumbolo, G. Franceschetti, E. Zoico, C. Bambace, L. Cominacini, and M. Zamboni LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1 murine adipocyte model Inflamm. Res. 63 2014 495 507
44. R. Rodriguez-Calvo, L. Serrano, T. Coll, N. Moullan, R.M. Sanchez, M. Merlos, X. Palomer, J.C. Laguna, L. Michalik, W. Wahli, and M. Vazquez-Carrera Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2 Diabetes 57 2008 2149 2157
45. F. E, R.E. Gerszten, T. Matsui, R.R. Hung, L. Li, T. Force, and A. Rosenzweig Role of phosphoinosiide 3-kinase in monocyte recruitment underflow conditions J. Biol. Chem. 276 2001 26846 26851
46. W. H, Y. Wang, V. Hedge, O. Dubuission, Z. Gao, N.V. Dhurandhar, and J. Ye Interplay of pro- and anti-inflammatory cytokines to determine lipid accretion in adipocytes Int. J. Obes. 37 2013 1490 1498
47. N.V. Dhurandhar, B.A. Israel, J.M. Kolesar, G.F. Mayhew, M.E. Cook, and R.L. Atkinson Increased adiposity in animals due to a human virus Int. J. Obes. Relat. Metab. Disord. 24 2000 989 996
48. N.V. Dhurandhar, B.A. Israel, J.M. Kolesar, G. Mayhew, M.E. Cook, and R.L. Atkinson Transmissibility of adenovirus-induced adiposity in a chicken model Int. J. Obes. Relat. Metab. Disord. 25 2001 990 996
49. H. Ghanim, K. Korzeniewski, C.L. Sia, S. Abuaysheh, T. Lohano, A. Chaudhuri, and P. Dandona Suppressive effect of insulin infusion on chemokines and chemokine receptors Diabetes Care 33 2010 1103 1108
50. O. Sekine, Y. Nishio, K. Egawa, T. Nakamura, H. Maegawa, and A. Kashiwagi Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells J. Biol. Chem. 277 2002 36631 36639
51. S.I. Brundage, N.N. Kirilcuk, J.C. Lam, D.A. Spain, and N.A. Zautke Insulin increases the release of proinflammatory mediators J. Trauma 65 2008 367 372
52. M. Leffler, T. Hrach, M. Stuerzl, R.E. Horch, D.N. Herndon, and M.G. Jeschke Insulin attenuates apoptosis and exerts anti-inflammatory effects in endotoxemic human macrophages J. Surg. Res. 143 2007 398 406